Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 8
Results: 25
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1405, doi. 10.1093/neuonc/noac164
- Publication type:
- Article
Leveraging epigenomic patterns to resolve the heterogeneity and origins of CNS germ cell tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1259, doi. 10.1093/neuonc/noac102
- By:
- Publication type:
- Article
Breaking the DLG shackles in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1243, doi. 10.1093/neuonc/noac092
- By:
- Publication type:
- Article
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1219, doi. 10.1093/neuonc/noac086
- By:
- Publication type:
- Article
Meeting the high expectations for liquid biopsy assays for pediatric brain tumors: Progress and challenges.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1364, doi. 10.1093/neuonc/noac083
- By:
- Publication type:
- Article
Identifying risk factors for recurrence/relapse in NF1 optic pathway gliomas: Moving forward by looking back.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1387, doi. 10.1093/neuonc/noac081
- By:
- Publication type:
- Article
Longitudinal monitoring of diffuse midline glioma using liquid biopsy.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1375, doi. 10.1093/neuonc/noac076
- By:
- Publication type:
- Article
Trends in location of death for individuals with primary brain tumors in the United States.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1400, doi. 10.1093/neuonc/noac075
- By:
- Publication type:
- Article
Improving survival in neuro-oncology is a struggle; we cannot allow ourselves to also struggle with issues of diversity.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1350, doi. 10.1093/neuonc/noac069
- By:
- Publication type:
- Article
TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPIT.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1286, doi. 10.1093/neuonc/noac053
- By:
- Publication type:
- Article
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1318, doi. 10.1093/neuonc/noac024
- By:
- Publication type:
- Article
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1246, doi. 10.1093/neuonc/noac021
- By:
- Publication type:
- Article
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1377, doi. 10.1093/neuonc/noac013
- By:
- Publication type:
- Article
scaffolding protein DLG5 promotes glioblastoma growth by controlling Sonic Hedgehog signaling in tumor stem cells.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1230, doi. 10.1093/neuonc/noac001
- By:
- Publication type:
- Article
population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1341, doi. 10.1093/neuonc/noac011
- By:
- Publication type:
- Article
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1273, doi. 10.1093/neuonc/noac052
- By:
- Publication type:
- Article
RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1261, doi. 10.1093/neuonc/noac051
- By:
- Publication type:
- Article
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1366, doi. 10.1093/neuonc/noac030
- By:
- Publication type:
- Article
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1404, doi. 10.1093/neuonc/noac029
- By:
- Publication type:
- Article
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1307, doi. 10.1093/neuonc/noac023
- By:
- Publication type:
- Article
Long-term natural history and patterns of sporadic vestibular schwannoma growth: A multi-institutional volumetric analysis of 952 patients.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1298, doi. 10.1093/neuonc/noab303
- By:
- Publication type:
- Article
Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1352, doi. 10.1093/neuonc/noab299
- By:
- Publication type:
- Article
Outcomes of intracranial germinoma—A retrospective multinational Asian study on effect of clinical presentation and differential treatment strategies.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1389, doi. 10.1093/neuonc/noab295
- By:
- Publication type:
- Article
Corrigendum to: Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1402, doi. 10.1093/neuonc/noab255
- By:
- Publication type:
- Article
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1331, doi. 10.1093/neuonc/noab294
- By:
- Publication type:
- Article